Sandi Peterson

Imagine swallowing the competition whole. That's what many players in tech do via roll-up strategies, gobbling up smaller firms to deliver richer solutions and amass greater market share. Where else are roll-up strategies common? // HEALTHCARE Picture being a patient at a medical practice that’s been part of a roll-up in Healthcare Services. It's an industry ripe for roll-ups due to its fragmented nature and potential for greater efficiency. // CONSUMER SERVICES Or let's say you needed your HVAC serviced, and notice your local repairman is now part of a bigger Consumer Services entity? Centralized management and scale economy turn these localized businesses into roll-up targets. // FINANCIAL SERVICES Think about your insurance agent or wealth management advisor. They're working in complex, highly regulated environments. In the Financial Services sector, roll-ups offer an effective way to consolidate expertise, streamline operations, and enhance customer offerings. // MANUFACTURING Now, imagine driving past factories under a new name — the result of Manufacturing and Industrial Services roll-ups. Bulk purchasing reduces costs, enhances production capabilities, and expands geographical footprints. // REAL ESTATE Lastly, envision your real estate brokerage firm. The industry sees roll-ups as a strategic move to increase market penetration, enhance service offerings, and hike up portfolio value. Roll-ups play a huge role in most industries, rather like a snowball rolling downhill, gaining momentum, and size. Are you seeing roll-ups in your sector or considering M&A?

11

1 Comment

Today's post is about our commitment at Bread and Butter Ventures to investing in women's health within our healthcare vertical, which is a big focus of our fund. Our mission in healthtech broadly is to invest in technology that democratizes access to quality care for all. A report this year from Deloitte shared that investment in women’s health rose by 5% between 2022 and 2023 - heading in the right direction, however, women's health represented just 2% of the $41.2 billion in venture funding that went to health companies in 2023, according to Deloitte’s analysis. There is such tremendous opportunity to innovate and invest for half the world's population. This an economic imperative. Spotlighting today 5 outstanding healthcare startups innovation in women's health who are very proud to have in our portfolio: ⭐ Gabbi: is building a comprehensive breast cancer risk assessment and early detection platform, combining cutting-edge technology with personalized care. As a woman's virtual breast specialist, Gabbi ensures every woman knows her risk and has access to early detection via telehealth. https://www.gabbi.com/. Shoutout Kaitlin Christine ⭐ Chiyo: is a personalized & integrative food-as-medicine platform that helps the next generation of mothers looking for guidance as they navigate the acute transitions of fertility, pregnancy and post-partum. https://wearechiyo.com/. Shoutout Irene Liu ⭐ Delfina: is creating an AI-powered pregnancy care platform to solve the global maternal health crisis. Delfina lowers rates of adverse outcomes, hospitalizations, and NICU stays to deliver substantial savings for health plans and risk-sharing providers. https://www.delfina.com/. Shoutout Senan Ebrahim, MD, PhD Priyanka Vaidya Ali Ebrahim ⭐ Nest Collaborative is the first to create a nationwide network of lactation consultants, available to mom 24/7 through virtual consultations. We were also the first to offer mom a no-cost, insurance-paid experience - which means when she has a problem we can connect her with a consultant within hours and we take care of all the payment and paperwork on the back end. We are, in all ways, her BFF - Breast Feeding Friend. https://lnkd.in/gKCVYvtF. Shoutout Judith Nowlin ⭐ Myya: provides breast cancer survivors completely customizable, fully insurance billable post-mastectomy prosthetics with a state-of-the-art fitting experience online and in-person. https://myya.com/ Jasmine Jones #womenshealth #digitalhealth #venturecapital #startups

92

4 Comments

The healthcare landscape is rapidly evolving, driven by advancements in technology and a deeper understanding of patient care. I had the pleasure of speaking with Ambar Bhattacharyya, Co-Managing Partner at Maverick Ventures, on the latest episode of The Full Ratchet. Ambar has partnered with numerous billion-dollar companies like hims & hers, Cityblock Health, Devoted Health, and ConcertAI. His unique journey from rural America to becoming a prominent figure in venture capital offers invaluable insights into the future of healthcare and technology. We discuss his investment strategy at Maverick Ventures, the megatrends shaping healthcare, the impact of AI on the industry, and the importance of integrated care. Ambar also shares his thoughts on the challenges and opportunities in healthcare investment, offering a comprehensive view of what lies ahead. Check out TFR Episode 438 to catch our conversation. You'll be glad you listened. Link to the full episode is in the comment section below.

117

8 Comments

Some VC investors believe that brick and mortar - referring to a physical presence of some kind - should be avoided at all costs. Yet, the track record of clinic and hybrid care businesses in health care indicates otherwise. ==> One Medical (sold for $3.9 billion to Amazon), Oak Street (bought by CVS for $10.6 billion), Lifestance (IPO at $7.5 billion market cap), and PE-backed Premise Health (acquired by OMERS Private Equity for $1.1 billion) If a clinic is indicated as the optimal way to deliver care for that patient population, there are creative ways to build and operate them. Full article below with advice and strategies on how to build and operate hybrid clinics from my teammate Anarghya Vardhana from Maveron, Amir Dan Rubin from OneMedical Group, Steven Eidelman from Modern Animal and more!

13

1 Comment

When is the right time for startups to consider going public? In this clip, Yassaman Salas, Partner, Global head of Medical Device at Goldman Sachs, explores the appropriate stage for companies to consider an IPO. She highlights how this decision should shape strategic planning early on and emphasizes the importance of revenue predictability in demonstrating readiness for an IPO. This discussion from #LSIEurope23, ‘Behind the Buyout: Navigating Strategic Partnerships & M&As From Both Sides of the Table’, gives a behind-the-scenes look at M&As and partnerships, explores strategies from both buyer and seller viewpoints, and shares real-world experiences to demystify the complexities of M&As. The full video recording of this panel featuring Ken Nelson, Nate Harrington, Kevin Rocco, Yassaman Salas, and Biren Mehta is available on our website and YouTube channel. Want to see more content like this? Registration and applications to present are open for LSI Europe ‘24 this September 16th - 20th at the Penha Longa Resort, in Portugal. Secure your spot today to ensure you get the best rate and secure a hotel room onsite.

10

According to the latest report from Rock Health, digital health funding in Q1 2024 totaled $2.7B across 133 deals, with an average deal size of $20.6M. It doesn’t break out device-related investments, but most medtech founders I meet these days are being forced to chase tiny rounds made up of endless little checks, consuming valuable energy and slowing their progress. The benign neglect of this next generation of diagnostic and therapeutic devices is counterproductive and surprising. Given the crowded virtual care market, for example, I’d expect more such companies would be exploring medtech partnerships, investments or acquisitions that'd enable them to back integrate into delivering sharper, and more differentiated, care and treatment. This is exactly what Maverix Medical is doing from the other direction: Reshaping the entire spectrum of lung cancer care by integrating more advanced + effective approaches to screening and diagnosis, treatment and therapeutics, and even palliative care…And putting it all to work through an innovative provider network. One notable investor exception is Y Combinator partner Surbhi Sarna who’s been backing great teams like Selera Medical (YC W24) doing foundational work on ambitious medical devices. Without more support from investors like her, we’re going to increasingly find ourselves stuck with the incremental portfolio improvements from the incumbents, and that’s just not nearly enough.

59

5 Comments

What is the shift to preventive and specialized healthcare services❓ Studies show that preventive health measures could save the U.S. healthcare system up to $3.7 billion annually by avoiding the need for costly treatments later on. Moreover, chronic diseases currently account for up to 90% of healthcare expenditures, yet many of these are preventable with earlier interventions. As healthcare leaders, we have a responsibility to build systems that address issues before they become crises. Investments in preventive and specialized care are steps toward a future where healthcare is proactive, not reactive. At Caresyntax, we’re committed to using #Data to advance preventive care. By integrating AI solutions, our data-driven platform provides insights into patient risks, helping reduce post-surgical complications and offering preventive solutions. 🌟 It’s exciting to see the industry recognizing the value of long-term health and wellness. By investing in these areas, we’re not only tackling today’s challenges but also building a foundation for a healthier, more resilient future. #FutureOfHealth #PreventiveCare #HealthcareInvestment #DigitalHealthInnovation

40

2 Comments

Healthcare is highly suited for AI automation, with many opportunities to improve accessibility, affordability, and outcomes. AI can drive efficiencies across various functions, though it will inevitably reduce the need for some human roles. #higherorder #ai #automation #healthcare #healthtech

6

Abby Levy talks about venture's role in US healthcare and what we can expect to see as technology impacts the space on TFR. Check out the rest of the conversation with Abby & Alan Patricof of Primetime Partners on Episode 433.

35

6 Comments

🚨 Healthcare M&A Update – September 2024 🚨 The healthcare sector remains active with significant merger and acquisition activity in Q2 2024. The median deal value stood at $50M, with strategic buyers driving 93% of transactions. Below are some notable M&A deals announced publicly this year: 💊 ANI Pharmaceuticals acquired Alimera Sciences for $400M in June. 💉 GSK completed its acquisition of Elsie Biotechnologies for $50M in the same month. 🏥 Nordson Medical Corporation secured Atrion Corporation for $815M in May. 🧬 Novartis AG expanded its oncology portfolio by acquiring Mariana Oncology for $1.8B in May. 🌍 Johnson & Johnson made headlines with its $13.9B acquisition of Shockwave Medical in April. The healthcare M&A space shows no signs of slowing down. Stay tuned for more updates as we move through the rest of 2024! #HealthcareMergers #MergersAndAcquisitions #HealthcareM&A #StrategicDeals #BusinessGrowth #PharmaAcquisitions #HealthcareInnovation #IndustryUpdates #CorporateStrategy #FinancialTrends #MedTech #BiotechAcquisitions

2

1 Comment

Healthcare Innovation and Investment News for the week from HDIG HDIG Search, Consulting and Venture HDIG is an ecosystem with a searchable database of hospital healthcare venture, innovation centers, tech transfer offices and their portfolio companies. It would assist you in understanding the landscape of partnerships, performance, and contacts. Early-stage companies use it to find partners and funding for their pilots, or even professional firms or tech companies depending on their needs. Launched this year with nearly 10,000 companies, hospitals, and funds, get full access for a special monthly subscription of only $100 and you can cancel at anytime, this would include building your profile. Learn more about our Acceleration Pilot Program, paid pilots, reverse studio model and other research and services. #HDIG #HealthcareInnovation #HealthcareVenture #HospitalInnovation

3

🎙️Excited to share my recent conversation on "The Business of HLTH" podcast where we delve into the dynamic intersection of finance and #lifesciences. As a #CFO dedicated to advancing the industry, I discuss the nuances of venture investing, M&A, and strategic financial planning that can propel life sciences organizations forward. 🔗Tune in to gain insights into how we at Tialma provide tailored CFO solutions that not only manage but enhance the financial and operational aspects of life sciences companies, ultimately maximizing shareholder value. Whether you're involved in biotech, medtech, or looking to understand the financial intricacies of the industry, this episode offers valuable perspectives. 👉Listen to the episode here: https://lnkd.in/e6Yx8swQ Feel free to connect and discuss how strategic financial leadership can make a measurable impact in the life sciences sector.

12

4 Comments

TL;DR: Solving a fundamental point of friction in US health care: affordability The LEAD team is excited to back The WiTT Group and Rahul Mahadevan in their latest financing round led by Sopris Capital to expand their impact efforts of distributing non-clinical support to patients more efficiently! "Financial toxicity for patients undergoing treatment in the U.S. healthcare system is a critical issue that needs urgent attention. What excites us about backing WiTT is its platform's unique ability to align incentives across key stakeholders and support patients in need in the community. It efficiently delivers financial and non-financial assistance to patients, driving improved treatment compliance for healthcare providers. We're excited to support their commercial expansion as they grow the most valuable, proprietary patient dataset focused on self-reported social determinants of health." CC: Thomas H. Rudy Kaiwen Liu Matthew Foran Sopris Capital Taylor Paul Abinav Sankar Charlie Regis Kendel Fiorentino

16

1 Comment

As I said right at the start of this week's The Heart of Healthcare Podcast, Shivdev Rao is one of the most exceptional founders I have ever worked with. He is also a great human being. In this week's episode he shares what is it like leading the 🚀 that is Abridge and some awesome life lessons. IMHO this is a great listen for founders building in both the AI and healthcare fields!

56

3 Comments

As physicians, we are committed to improving patient care through clinical excellence. However, there's an often-overlooked avenue where our expertise can significantly impact healthcare innovation: serving as medical advisors for startups. Here are a few reasons why I believe we should engage with the entrepreneurial community 👇 1️⃣ Driving Innovation Forward: Startups are at the forefront of medical technology and services. By contributing our clinical expertise, we can guide these companies to develop solutions that are not only innovative but also practical and patient-centered. 2️⃣ Broadening Impact: While our primary influence is within the confines of our practices or hospitals, working with startups allows us to extend our impact globally. Technologies we help develop could benefit patients worldwide, many of whom could never visit us in person. 3️⃣ Learning and Growth: Engaging with startups exposes us to the latest technologies and business strategies, enriching our understanding beyond the medical field. This cross-disciplinary knowledge can enhance our own practices and the way we approach patient care. 4️⃣ Professional Networking: Collaborating with entrepreneurs and other tech innovators can open new doors. These connections can lead to other advisory roles, speaking opportunities, and even advancements in our own careers. 5️⃣ Financial Opportunities: Often, advising roles come with financial compensation, including equity options. These can provide significant financial benefits, particularly if the startup succeeds. 6️⃣ I urge my fellow clinicians to consider stepping into the role of a medical advisor. Our insights are invaluable, and our participation can be the key differentiator in the success of health-focused innovations. ---- Join our vibrant community of 2,000+ healthtech experts and thought leaders. Comment below or DM me, and I’ll provide you with an invitation to our fast-growing network. 📩

50

9 Comments

Big news from Karoo Health today. This partnership will accelerate their ability to deliver value based care (VBC) for cardiovascular disease. If you are frustrated with America's healthcare system, VBC will give you reasons to be hopeful. Not only does it drive down costs, but it is better care. Initial data shows 29% of patients using Karoo's model have been diverted from at least one unnecessary ER visit. That's huge savings for our healthcare system and a huge impact on those patients' lives...a true win-win.

13

1 Comment

I’ve had the chance to go deep with a number of digital health alum, healthcare mentors and #corporate innovation partners over the past few days. A few themes to share:   1. Digital will change healthcare. Period. How is hard. But it will happen and the best are continuing to push ahead. 2. What keeps companies in the S&P 500 for 50 years or more? Partnerships and innovation. This is why large systems must practice the hard art of both partnership and partnership towards innovation. For startups, partnership reps may be more important than brand. 3. There is a difference between needs and behaviors that startups need to understand, especially in Healthcare where incentives, process, practices are complex. Finding who pays early is not only essential but existential. 4. Don’t optimize for valuation, optimize for value. Over the long-run, this is what will matter. In Healthcare, today value will have to tie to ROI. Pharma, providers, payors are under pressure. Your solution needs to be must-have and drive ROI.   MC Healthcare was launched over 5 years ago to accelerate industry/startup intelligence and collaboration and commercial partnerships for digital health startups and industry (payors, providers, pharma). Calling startups to apply. Want to be a partner to find and work with the best? DM me directly.

33

1 Comment

#plasticsurgery, #dermatolgy, and #medspa owners, and any investment bank or advisor that represents one - JSTAR Holdings is actively investing in the sector (and a symbiotic partner for growth). Let's just share insights, or we can quickly give feedback and our interest in a potential partnership/investment opportunity. The next billion dollar practices are being forged today, let's get going. And btw, we invest in a lot of other sectors too. Don't hesitate to reach out. #privateequity #pe #capitalpartner #entrepreneur #growthcapital

14